Let's Talk Medtech: Why Embecta Stands Out in Diabetes Care
Apr 01, 2022•24 min•Season 1Ep. 38
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
Embecta is now fully independent from Becton Dickinson & Co. Devdatt Kurdikar, Embecta's CEO talks about what that means going forward and his plans for the company. With its rich pedigree and newly-independent status, Embecta is truly the new/old kid on the block in diabetes care.
For the best experience, listen in Metacast app for iOS or Android